Expression of P-selectin and intercellular adhesion molecule-1 in human brain after focal infarction or cardiac arrest

Neuropathology and Applied Neurobiology

Volumn 27, Issue 6, 2001, Pages 465-473

  Love, S ^a   Barber, R ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Adhesion molecules; Brain ischaemia; Cardiac arrest; Endothelium; ICAM 1; Inflammation; P selectin; Stroke

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN TISSUE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART ARREST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; NEUTROPHIL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOCYTE;

ADULT; AGED; BRAIN CHEMISTRY; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHILD, PRESCHOOL; ENCEPHALITIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART ARREST; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; P-SELECTIN;

EID: 0035728356     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2001.00356.x     Document Type: Article

References (49)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
2. The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats
3. Inflammation and acute stroke
4. Humanized anti-L-selectin monoclonal antibody DREG200 therapy in acute thromboembolic stroke
5. Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke
6. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy
7. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat
8. Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
9. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain
10. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke
11. The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy
12. Inflammation and stroke: Putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia
13. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets
14. Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: Post hoc analysis of ECASS I
15. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)
16. Significance of the inflammatory response in brain ischemia
17. Intracerebral inflammation after human brain contusion
18. x-glycosylated complement inhibitory protein
19. Deficiency of intercellular adhesion molecule 1 attenuates micro-circulatory disturbance and infarction size in focal cerebral ischemia
20. Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice
21. Effects of tissue plasminogen activator for acute ischemic stroke at one year
22. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke
23. x for the treatment of ischemic strokes
24. Activation of caspase-3 in permanent and transient brain ischaemia in man
25. Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man
26. Neuronal accumulation of poly(ADP-ribose) after brain ischaemia
27. Neuronal death in brain infarcts in man
28. rtPA in acute ischemic stroke: The North American perspective
29. Expression of cell adhesion molecules by microvascular endothelial cells in the cortical and subcortical regions of the normal human brain: An immunohistochemical analysis
30. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion
31. CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke
32. TWEAK stimulation of astrocytes and the proinflammatory consequences
33. Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): An open-label, dose escalation study in patients hospitalized for acute stroke
34. Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury
35. Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults
36. Selective expression of adhesion molecules on human brain microvascular endothelial cells
37. Reduction of ischemic brain injury by anti-P-selectin monoclonal antibody after permanent middle cerebral artery occlusion in rat
38. Anti-P-selectin antibody attenuates rat brain ischemic injury
39. The enlimomab acute stroke trial: Final results
40. Cerebral malaria
41. An immunohistochemical study of the pathology of fatal malaria: Evidence for widespread endothelial activation and a potential role for ICMA-1 in cerebral sequestration
42. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood
43. Soluble adhesion molecules in CSF are increased in children with severe head injury
44. Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia
45. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat
46. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat
47. E-selectin in focal cerebral ischemia and reperfusion in the rat
48. Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat
49. Postischemic treatment (2-4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat